Read-Gene S.A. (WSE:RDG)
 6.00
 0.00 (0.00%)
  At close: Oct 31, 2025
Read-Gene Revenue
Read-Gene had revenue of 3.43M PLN in the quarter ending June 30, 2025, with 15.43% growth. This brings the company's revenue in the last twelve months to 15.13M, up 29.99% year-over-year. In the year 2024, Read-Gene had annual revenue of 13.23M with 30.38% growth.
Revenue (ttm) 
 15.13M
Revenue Growth 
 +29.99%
P/S Ratio 
 4.68
Revenue / Employee 
 687.67K
Employees 
 30
Market Cap 
70.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 13.23M | 3.08M | 30.38% | 
| Dec 31, 2023 | 10.15M | 2.91M | 40.14% | 
| Dec 31, 2022 | 7.24M | 787.35K | 12.20% | 
| Dec 31, 2021 | 6.45M | 384.57K | 6.34% | 
| Dec 31, 2020 | 6.07M | -296.62K | -4.66% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| NEUCA | 13.04B | 
| Diagnostyka | 2.17B | 
| Centrum Medyczne ENEL-MED | 789.78M | 
| Synektik Spólka Akcyjna | 623.20M | 
| Mercator Medical | 579.83M | 
| Voxel | 560.38M | 
| Selvita | 373.90M | 
| Celon Pharma | 206.22M |